{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:05:44Z","timestamp":1794265544803,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.msard.2021.102940","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T22:55:29Z","timestamp":1617922529000},"page":"102940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"52","author":[{"given":"Li","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2021.102940_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.msard.2021.102940_bib0016","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma Cell Survival Is Mediated by Synergistic Effects of Cytokines and Adhesion-Dependent Signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.msard.2021.102940_bib0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ni.1981","article-title":"Eosinophils are required for the maintenance of plasma cells in the bone marrow","volume":"12","author":"Chu","year":"2011","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.msard.2021.102940_bib0015","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.msard.2021.102940_bib0012","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jaip.2018.04.031","article-title":"Eosinophils: friends or Foes?","volume":"6","author":"Chusid","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.msard.2021.102940_bib0013","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between Interleukin-5 and the Chemokine Eotaxin to Induce Eosinophil Accumulation in-Vivo","volume":"182","author":"Collins","year":"1995","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.msard.2021.102940_bib37","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","article-title":"Activation of humoral immunity and eosinophils in neuromyelitis optica","volume":"63","author":"Correale","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2021.102940_bib0031","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1352458510392619","article-title":"Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis","volume":"17","author":"Correale","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2021.102940_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in Autoimmune Diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.msard.2021.102940_bib0033","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.molimm.2005.07.015","article-title":"Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines","volume":"43","author":"Duchesnes","year":"2006","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.msard.2021.102940_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0031-6997(24)01404-2","article-title":"Pharmacology of the eosinophil","volume":"51","author":"Giembycz","year":"1999","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.msard.2021.102940_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2015.07.008","article-title":"Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis","volume":"43","author":"Griseri","year":"2015","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.msard.2021.102940_bib0026","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"issue":"5678","key":"10.1016\/j.msard.2021.102940_bib0024","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1089926","article-title":"Promotion of B cell immune responses via an alum-induced myeloid cell population","volume":"304","author":"Jordan","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.msard.2021.102940_bib0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaci.2012.07.025","article-title":"Human versus mouse eosinophils: \"that which we call an eosinophil, by any other name would stain as red","volume":"130","author":"Lee","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.msard.2021.102940_bib0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.msard.2021.102940_bib0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.micinf.2011.12.002","article-title":"Chemokines and cytokines in patients with an occult Onchocerca volvulus infection","volume":"14","author":"Lechner","year":"2012","journal-title":"Microbes Infect"},{"issue":"Pt 7","key":"10.1016\/j.msard.2021.102940_bib0004","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2021.102940_bib0034","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/prot.10238","article-title":"Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines","volume":"50","author":"Mayer","year":"2003","journal-title":"Proteins"},{"issue":"6","key":"10.1016\/j.msard.2021.102940_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","author":"Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.msard.2021.102940_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2013.07.019","article-title":"Post-acute serum eosinophil and neutrophil-associated cytokine\/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.msard.2021.102940_bib0027","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jocn.2017.10.074","article-title":"Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis","volume":"48","author":"Muroishi","year":"2018","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.msard.2021.102940_bib0021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol."},{"issue":"14","key":"10.1016\/j.msard.2021.102940_bib0025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318214332c","article-title":"Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications","volume":"76","author":"Popescu","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2021.102940_bib0006","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","article-title":"Neuromyelitis optica IgG causes placental inflammation and fetal death","volume":"191","author":"Saadoun","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.msard.2021.102940_bib0023","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/icb.2009.115","article-title":"Eosinophils and Th2 immunity: contemporary insights","volume":"88","author":"Spencer","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.msard.2021.102940_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576967","article-title":"CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis","volume":"333","author":"Shou","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.msard.2021.102940_bib0019","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fneur.2018.00044","article-title":"Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission","volume":"9","author":"Tong","year":"2018","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.msard.2021.102940_bib0022","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1352458515601903","article-title":"Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later","volume":"22","author":"Uher","year":"2016","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.msard.2021.102940_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2021.102940_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163751","article-title":"IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF","volume":"11","author":"Willebrand","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.msard.2021.102940_bib0005","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI67554","article-title":"Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica","volume":"123","author":"Zhang","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821002078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821002078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:52:04Z","timestamp":1761900724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"alternative-id":["S2211034821002078"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102940","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102940"}}